James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence

Valeant Pharmaceuticals (VRX) finds relief as John Paulson joins the board, but what can he really do to help VRX stock holders?

What Does Amazon.com Inc. (AMZN) Stock Get With Whole Foods? Marketing Gold.

Amazon (AMZN) stock holders may not be able to discern the benefits yet, but there's little doubt of the value of Whole Foods for AMZN stock.

Why Snap Inc (SNAP), Kroger Co (KR) and Brinker International, Inc. (EAT) Are 3 of Today’s Worst Stocks

Brinker International (EAT), Kroger (KR) and Snap (SNAP) couldn't win for losing on Thursday, albeit for understandable reasons.

Sell iRobot Corporation (IRBT) Stock for a Huge Profit While You Still Can

iRobot (IRBT) is a fine company that is "the" name in cleanings robots. IRBT stock, however, has gotten ahead of itself.

Tesla Inc (TSLA) Stock Moves Have Become Predictable, to a Point

Tesla stock looks like it hit a wall last week, but don't count it out just yet. This is all just part of the TSLA trading game.